Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Liothyronine sodium hydrate (Triiodothyronine sodium hydrate) is a TRα and TRβ agonist and a thyroxine analog with anticancer and antitumor activities. It can be used to study hypothyroidism, stroke and cognitive dysfunction.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 50 mg | $35 | In Stock | 
| Description | Liothyronine sodium hydrate (Triiodothyronine sodium hydrate) is a TRα and TRβ agonist and a thyroxine analog with anticancer and antitumor activities. It can be used to study hypothyroidism, stroke and cognitive dysfunction.  | 
| Targets&IC50 |  TRα (human):2.33 nM, TRβ (human):2.33 nM  | 
| In vitro | b>METHODS: Liothyronine sodium hydrate (100 μM, 3 weeks) was used to treat liver cancer cells (Mahlavu, SK-Hep-1, J5, 5328 and HepG2) and the cell growth was observed. RESULTS: Liothyronine sodium hydrate can stimulate the proliferation of liver cancer cells. [1]  | 
| Synonyms | Triiodothyronine sodium hydrate, T3 sodium hydrate, 3,3',5-Triiodo-L-thyronine sodium hydrate | 
| Formula | C15H11NNaO4 xH2O | 
| Cas No. | 345957-19-9 | 
| Smiles | IC(C=C(C=C1I)C[C@H](N)C([O-])=O)=C1OC2=CC(I)=C(C=C2)O.[Na+].O xH2O | 
| Color | Yellow | 
| Appearance | Solid | 
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.